Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab plus letrozole versus letrozole alone in first-line hormone therapy for recurrent or metastatic breast cancer
2007-002841-19Phase 3Completed
- Sponsor
- GEICAM
- Start
- Jul 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial in breast cancer comparing Bevacizumab + letrozole with Letrozole alone (2 arms). Primary endpoint: Progression-free survival. Started Jul 2007; status: completed.
02
Drugs
bevacizumabletrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2007-002841-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002841-19.